A Phase 3, Randomized, Controlled, Open-Label Study to Evaluate the Persistence Up to 5 Years of 1 or 2 Doses of Meningococcal Conjugate Vaccine MenACWY-TT Given with or Without 13-Valent Pneumococcal Conjugate Vaccine in 12–14-Month-old Children
VACCINE（2023）
Key words
MenACWY-TT,Meningococcal disease,Vaccination,Children,Immunogenicity,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined